BioGend Therapeutics6733 
$1.200.79%24h
0.79%24h
Global rank19135
Market cap$147.30M
Change 7d3.66%
YTD Performance-0.13%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of BioGend Therapeutics (6733)
As of September 2024, BioGend Therapeutics has a market cap of $147.30M. This makes BioGend Therapeutics the world's 19135th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of BioGend Therapeutics from 2019 to 2024
-
Value:-
Market cap history of BioGend Therapeutics from 2019 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $154.81M | 5.10% |
| 2023 | $147.30M | 73.08% |
| 2022 | $85.11M | -17.38% |
| 2021 | $103.02M | -30.34% |
| 2020 | $147.88M | 28.86% |
| 2019 | $114.76M | - |
6733 Market Cap Today is $147.30M 0.79% - 18 Sept 2024
View largest stocks by market cap 
